RIPK1 and breast carcinoma: A proliferative/antiapoptotic impact of miR-155 in breast cancer cells is mediated via caspase-3, Fas-associated death domain (FADD), receptor-interacting protein 1 (RIP-1), and apoptosis peptidase activating factor-1 (APAF-1) [120].